Genetic Tools for Analysis of FoxP3+ Regulatory T Cells In Vivo

Methods in Molecular Biology

Volumn 707, Issue , 2011, Pages 105-118

  Jeremiah, Nadia M ^a   Liston, Adrian ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cre Lox; Foxp3; In vivo; Knock in; Knock out; Transgenic; Treg

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE;

ANIMAL; ARTICLE; METABOLISM; MOUSE; REGULATORY T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; FORKHEAD TRANSCRIPTION FACTORS; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES, REGULATORY;

EID: 79955695563     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61737-979-6_8     Document Type: Chapter

References (38)

1. Russell WL, Russell LB, Gower JS. (1959) Exceptional inheritance of a sex-linked gene in the mouse explained on the basis that the X/O sex-chromosome constitution is female. Proc Natl Acad Sci U S A; 45: 554–60.
2. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA et al. (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet; 27: 68–73.
3. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L et al. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet; 27: 20–1.
4. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N et al. (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet; 27: 18–20.
5. Pirie E, Beutler B, Mutagenetix. (2008) Record for “crusty”, updated November 14, 2008 J:141212. MGI Direct Data Submission.
6. Fontenot JD, Gavin MA, Rudensky AY. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol; 4: 330–6.
7. Lin W, Truong N, Grossman WJ, Haribhai D, Williams CB, Wang J et al. (2005) Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J Allergy Clin Immunol; 116: 1106–15.
8. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity; 22: 329–41.
9. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature; 441: 235–8.
10. Haribhai D, Lin W, Relland LM, Truong N, Williams CB, Chatila TA. (2007) Regulatory T cells dynamically control the primary immune response to foreign antigen. J Immunol; 178: 2961–72.
11. Wang Y, Kissenpfennig A, Mingueneau M, Richelme S, Perrin P, Chevrier S et al. (2008) Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T Cells. J Immunol; 180: 1565–75.
12. Wan YY, Flavell RA. (2005) Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci U S A; 102: 5126–31.
13. Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA et al. (2007) Foxp3-dependent programme of regulatory T-cell differentiation. Nature; 445: 771–5.
14. Wan YY, Flavell RA. (2007) Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature; 445: 766–70.
15. Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. (2010) Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature; 463: 808–12.
16. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z et al. (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science; 322: 271–5.
17. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X et al. (2008) Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity; 28: 546–58.
18. Kim JM, Rasmussen JP, Rudensky AY. (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol; 8: 191–7.
19. Liston A, Nutsch KM, Farr AG, Lund JM, Rasmussen JP, Koni PA et al. (2008) Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc Natl Acad Sci U S A; 105: 11903–8.
20. Kuczma M, Podolsky R, Garge N, Daniely D, Pacholczyk R, Ignatowicz L et al. (2009) Foxp3-deficient regulatory T cells do not revert into conventional effector CD4+ T cells but constitute a unique cell subset. J Immunol; 183: 3731–41.
21. Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G et al. (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med; 204: 57–63.
22. Feuerer M, Shen Y, Littman DR, Benoist C, Mathis D. (2009) How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity; 31: 654–64.
23. Zhou X, Jeker LT, Fife BT, Zhu S, Anderson MS, McManus MT et al. (2008) Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med; 205: 1983–91.
24. Suffner J, Hochweller K, Kuhnle MC, Li X, Kroczek RA, Garbi N et al. (2010) Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3 LuciDTR mice. J Immunol; 184: 1810–20.
25. Guo L, Tian J, Marinova E, Zheng B, Han S. (2010) Inhibition of clonal expansion by Foxp3 expression as a mechanism of controlled T-cell responses and autoimmune disease. Eur J Immunol; 40: 71–80.
26. Liston A, Farr AG, Chen Z, Benoist C, Mathis D, Manley NR et al. (2007) Lack of Foxp3 function and expression in the thymic epithelium. J Exp Med; 204: 475–80.
27. Williams LM, Rudensky AY. (2007) Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol; 8: 277–84.
28. Chikuma S, Bluestone JA. (2007) Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease. Eur J Immunol; 37: 1285–9.
29. Schmidt KN, Hsu CW, Griffin CT, Goodnow CC, Cyster JG. (1998) Spontaneous follicular exclusion of SHP1-deficient B cells is conditional on the presence of competitor wild-type B cells. J Exp Med; 187: 929–37.
30. Almeida AR, Legrand N, Papiernik M, Freitas AA. (2002) Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol; 169: 4850–60.
31. Scott-Browne JP, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot JD, Rudensky AY et al. (2007) Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med; 204: 2159–69.
32. Liston A, Lu LF, O’Carroll D, Tarakhovsky A, Rudensky AY. (2008) Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med; 205: 1993–2004.
33. Chong MM, Rasmussen JP, Rudensky AY, Littman DR. (2008) The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med; 205: 2005–17.
34. Kohm AP, McMahon JS, Podojil JR, Begolka WS, DeGutes M, Kasprowicz DJ et al. (2006) Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J Immunol; 176: 3301–5.
35. Couper KN, Blount DG, de Souza JB, Suffia I, Belkaid Y, Riley EM. (2007) Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice. J Immunol; 178: 4136–46.
36. Buch T, Heppner FL, Tertilt C, Heinen TJ, Kremer M, Wunderlich FT et al. (2005) A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat Methods; 2: 419–26.
37. Lahl K, Mayer CT, Bopp T, Huehn J, Loddenkemper C, Eberl G et al. (2009) Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice. J Immunol; 183: 5662–72.
38. Nor JE, Hu Y, Song W, Spencer DM, Nunez G. (2002) Ablation of microvessels in vivo upon dimerization of iCaspase-9. Gene Ther; 9: 444–51.